Syneos Health Identifies Important Drivers of Change Expected to Disrupt Healthcare
MORRISVILLE, N.C., Feb. 11, 2021 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, is pulsing a series of 2021 Health Trends – Speed and Scale in the Great Disruption, offering new insights into the key drivers of growth for the life sciences and health sectors in the year ahead. Syneos Health is now providing its annual predictions in a staged release format, detailing the most significant and actionable trends driving biopharmaceutical growth for the next decade.
“We enter 2021 energized and humbled by the impact of COVID-19 on the world and the healthcare industry, and in awe of the overwhelming response to this crisis,” said Leigh Householder, Managing Director, Omnichannel Strategy and Trends Editor for Syneos Health. “For a decade, Trends has served as an accelerant to the ongoing ideas, priorities and focus to improving health. We do not see that whiplash of change slowing, and the investments being made to meet the demands of a new approach to health will continue to spark developments.”
As Syneos Health experts continue to monitor and identify trends anticipated to reshape the biopharmaceutical landscape and accelerate growth and impact, four overarching themes emerged as game-changers for patients, healthcare providers, biopharmaceutical companies, and other industry stakeholders:
“At Syneos Health, we are innovating with and for our clients, and driving change in how we deliver integrated clinical and commercial solutions,” added Householder. “Given COVID-19’s disruption, we remain grounded in providing the most relevant solutions, and high-value content, to our customers, patients, vendors and sites as new healthcare dynamics continue to unfold every day.”
About Syneos Health